FDA Approves 1st Immunotherapy Drug For Breast Cancer

The FDA approved the first immunotherapy drug to treat breast cancer: Tecentriq.

Created by Swiss drugmaker, Roche, Tecentriq was approved on Friday for treating advanced triple-negative breast cancer. The drug will be used with chemotherapy and works by boosting the immune system’s ability to spot and kill cancer cells.

Cost?

A whopping $13,400 per month.

Image Source: Tecentriq

Previous
EU Will Soon Require U.S. Travelers To Get A Visa
FDA Approves 1st Immunotherapy Drug For Breast Cancer

Processing...
Thank you! Your subscription has been confirmed. You'll hear from us soon.
Subscribe for news in an instant.
ErrorHere